In melanoma, high CCL27 expression in the supratumoral epidermis is associated with longer tumor-free survival (103, 112, 113), whereas CCL27 downregulation in metastases and advanced SCC/BCC may represent an immune evasion strategy (103, 105). Here, CCL27 is linked to neoplasm.